Lifevantage Corporation Common Stock (Delaware)

$9.030
USD
Last updated on --.
24h volume505.34K
24h highest9.6000 USD
24h lowest8.8000 USD
24h Price movement-4.85%

LFVN recent prices

24 Hours
-4.85%-$0.46
30 days
+80.74%+$4.255
60 days
+128.42%+$5.355
90 days
+83.43%+$4.330

Key data

Previous close9.4900 USD
Market cap125.78M USD
Volume505.34K
P/E ratio21.870000
Dividend yield (TTM)0.02%
Dividend amount0.050000 USD
Next ex-dividend dateJun 1, 2026
Next payment dateJun 15, 2026
EPS diluted (TTM)0.46000 USD
Net income (FY)5.75M USD
Revenue (FY)195.32M USD
Last report dateMay 6, 2026

About Lifevantage Corporation Common Stock (Delaware)

PHARMACEUTICAL PREPARATIONS
HeadquartersLEHI
Employees (FY)238.00
Revenue per employee (FY)820.68K USD
Net income per employee (FY)24.17K USD
Listed onNasdaq
Official website

LFVN conversion tables

LFVNLFVN
USDUSD
0.5 LFVN4.515 USD
1 LFVN9.030 USD
5 LFVN45.15 USD
10 LFVN90.3 USD
USDUSD
LFVNLFVN
0.5 USD0.055371 LFVN
1 USD0.11074 LFVN
5 USD0.55371 LFVN
10 USD1.107 LFVN

FAQ

LFVN is trading at $9.030, -4.85% over the last 24 hours. Track live moves on the price chart at the top of this page.
The LFVN stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. LFVN is currently trading at $9.030, -4.85% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on LFVN price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. LFVN's P/E ratio is currently 21.870000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from LFVN; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against LFVN's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Lifevantage Corporation Common Stock (Delaware)'s market cap is currently 125.78M USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume505.34K
24h highest9.6000 USD
24h lowest8.8000 USD
24h Price movement-4.85%
LFVNLFVN
USDUSD
Start trade with LFVN Perpetual